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Abstract 
Objectives: To estimate the prevalence and determine the factors associated with the use of 
antibiotics in the management of non-bloody diarrhoea in children under 5 years of age in Sub-
Saharan Africa (SSA). 
Methods: We conducted a meta-analysis of demographic and health survey datasets from 30 
countries in SSA. Pooled prevalence estimates were calculated using random effects model. 
Chi-square tests were employed to determine the factors associated with antibiotic use.  
Results: The pooled prevalence of antibiotic use among cases of non-bloody diarrhoea in 
children under 5 years of age was 23.1% (95% CI 19.5 – 26.7). The use of antibiotics in 
children with non-bloody diarrhoea in SSA was associated with (p < 0.05) the source of care, 
place of residence, wealth index, maternal education and breast feeding status.  
Conclusion: We found an unacceptably high use of antibiotics to treat episodes of non-
bloody diarrhoea in children under the age of 5 in SSA. 
What is known about this topic? 
 The appropriate treatment of diarrhoea is simple, yet it remains a problem in many 
low and middle income countries. 
 Most cases of non-bloody diarrhoea in children are self-limiting and are caused by 
microorganisms which are not susceptible to antibiotic therapy 
 Use of antibiotics to treat non-bloody diarrhoea in children increases the risk of 
adverse effects and the development of resistant bacteria. 
What this study adds? 
 We utilised nationally representative data to estimate the prevalence of antibiotic use 
in episodes of non-bloody diarrhoea in children under the age of 5 in SSA. 
 We found over one-in-five cases of non-bloody diarrhoea were treated with 
antibiotics in SSA 
 We highlight the need to educate prescribers and parents in SSA on appropriate 
management of diarrhoea and the consequences of inappropriate use of antibiotics 
in children. 
Introduction 
Diarrhoea is one of the leading cause of morbidity and mortality in children under five years 
old worldwide with about 1.7 billion episodes and 578,000 deaths every year.1 Most of these 
episodes and deaths occur among children in Africa with about 440 million cases and 350,000 
deaths annually.2 
The appropriate treatment of diarrhoea is simple, yet it remains a problem in many low and 
middle income countries (LMICs). Recent reviews of diarrhoea management in children in 
LMICs have revealed a high degree of inappropriate practise including excessive fluid 
curtailment and antibiotic prescribing.3-5 The existing WHO guideline recommends the use of 
oral rehydration solution (or an intravenous electrolyte solution in cases of severe dehydration) 
as well as zinc supplementation and continued feeding for the treatment and management of 
diarrhoea in children.6 The guideline only recommends the use of antibiotics in cases of bloody 
diarrhoea, suspected cholera or associated sepsis.  
The inappropriate use of antibiotics in children with diarrhoea can result in the development of 
antibiotic resistance. In addition, the majority of antibiotics can increase the risk of diarrhoea 
because of their effect on gut microflora.7 Very few studies have focussed on understanding 
the extent of antibiotic use in episodes of non-bloody diarrhoea in children in SSA. Rogawski 
et al.8 reported that 48.2% and 21.5% of cases of non-bloody diarrhoea in Haydom in Tanzania 
and Venda in South Africa, respectively were treated with antibiotics. Also, Opondo et al.9 
found that 64.5% of cases of non-bloody diarrhoea in children were treated inappropriately 
with antibiotics in eight district hospitals in Kenya. However, these studies were not nationally 
representative and did not explore the factors associated with the use of antibiotics in children 
with non-bloody diarrhoea. We conducted a meta-analysis of demographic and health survey 
(DHS) datasets from 30 countries in SSA to determine the prevalence and factors associated 
with the use of antibiotics in children with non-bloody diarrhoea.  
Methods 
Data source 
We conducted a meta-analysis of DHS data on the treatment of non-bloody diarrhoea with 
antibiotics in children under the age of 5 in 30 countries in sub-Saharan Africa. DHS are 
nationally-representative household surveys conducted by ICF Macro/MEASURE DHS on 
behalf of national ministries of health with financial support from many international partners 
including the United States Agency for International Development.10 The standard DHS uses 
identical methodology including the probability sampling strategy and survey instrument to 
collect data that are comparable across countries. 
Our study only included country datasets that were collected from 2000 to 2016 and contained 
disaggregated data on the type of diarrhoea- bloody and non-bloody diarrhoea in children 
under the age of 5. The datasets of 38 countries in SSA were available from DHS programme 
website. Of these 38 datasets, 30 met the inclusion criteria. Details of the included countries 
are contained in Figure1.  
Data analysis 
All DHS datasets were downloaded with permission from the DHS programme website and 
the data were analysed using Stata version 14 and Microsoft Excel 2016.  
The variables from the DHS datasets extracted and included in our analysis were prevalence 
of children with diarrhoea; type of diarrhoea, whether bloody or non-bloody; proportion of 
children treated/untreated; proportion of children who were treated for diarrhoea, type and 
sources  of treatment. Other variables included were the socio-demographics characteristics 
of children and their households including age and sex of child, mother’s educational level, 
wealth index of households, type and geographical location of child’s residence.  
We employed a random effects meta-analysis to calculate pooled prevalence estimates of the 
use of antibiotics in children with diarrhoea. A random effects meta-analysis was used 
because it allows for heterogeneity across studies. Despite the similarity of the DHS study 
design across countries, we expected heterogeneity due to differing population parameters 
including geographical distribution and socioeconomic conditions in different countries and 
regions of SSA. A test of heterogeneity of the DHS data obtained for the different countries 
showed a high level of inconsistency (I2 > 50%) thereby agreeing with our decision to use the 
random effects model in our analysis. Furthermore, we performed sensitivity analysis by 
excluding from our analysis one country data at a time and the impact of excluding the data 
was evaluated on the summary results. This was done to examine the effect of outliers and 
test the robustness of our findings.   
Subgroup analyses were performed to determine whether factors such as sex, age, type of 
residence, wealth index, education and sources of care were associated with the use of 
antibiotics in children under 5 years of age in SSA. The chi-square tests for association, or 
where appropriate for trend were calculated and results were considered statistically 
significant at p < 0.05.  
Results 
The datasets from the 30 countries covered 287,624 children under 5 years of age.  Overall, 
the pooled prevalence of all types of diarrhoea was 15.7% (95% CI 14.0 – 17.4) while the 
prevalence estimate for non-bloody diarrhoea was 12.8% (95% CI: 11.4 – 14.2). The majority 
of the cases of non-bloody diarrhoea were attended to in government health centres (17.6%), 
government hospitals (8.9%), government health posts or dispensaries (7.4%), shops (6.6%), 
community pharmacies (4.0%) and private hospitals/clinics (3.8%). 
The pooled prevalence of antibiotic use among cases of non-bloody diarrhoea in children 
under 5 years of age was 23.1% (95% CI 19.5 – 26.7). Antibiotics were commonly used among 
cases of non-bloody diarrhoea in Congo-Brazzaville 58.6% (95% CI 55.9 – 61.3) and Sierra 
Leone 47.1% (95% CI 43.9 – 50.3) (Figure 1). The regional estimate was lowest in east Africa 
18.7% (95% CI 13.9 – 23.6) and highest in central Africa 27.6% (95% CI 16.9 – 38.3).  The 
higher estimate in central Africa was due to the contribution of Congo-Brazzaville. The 
sensitivity analysis conducted by excluding the Congo-Brazzaville data yielded a pooled 
estimate of 21.8% in the central region, which is comparable to southern African region. The 
SSA pooled estimate obtained following the sensitivity analysis (21.9%, 95% CI 18.8 – 24.9) 
was comparable to our previous estimate.  
Table 1 summarises data based on the sub-group analyses performed. The subgroup 
analyses suggested that the use of antibiotics in children with non-bloody diarrhoea in SSA 
was significantly associated with (p < 0.05) the source of care, type of residence, wealth index, 
maternal education and breast feeding status. The results revealed that antibiotics were 
commonly used in children who sought advice or treatment from private hospitals/clinic and 
community pharmacies with pooled estimates of 41.1% (95% CI 34.1 – 47.4) and 41.8% (95% 
CI 34.8 – 48.9), respectively. 
Discussion 
The main contributions of our study lie in the use of nationally-representative data, the 
comprehensiveness of the factors explored and the application of meta-analysis to provide 
pooled estimates on the prevalence of antibiotic use in episodes of non-bloody diarrhoea in 
children under the age of 5 in SSA. We found a high use of antibiotics to treat episodes of 
non-bloody diarrhoea in children under the age of 5 in SSA: over one-in-five cases of non-
bloody diarrhoea were treated with antibiotics. Most cases of non-bloody diarrhoea in children 
are self-limiting and caused by microorganisms which are not susceptible to antibiotic therapy 
such as rotavirus or for which the efficacy of antibiotic therapy is somewhat uncertain such as 
in campylobacter infections.9,11 Up to 13% of cases of non-bloody diarrhoea are due to Shigella 
spp or enteroinvasive  Escherichia coli,12 which may justify antibiotics in children with severe 
toxicity or systemic symptoms of sepsis.  However the high rates of antibiotic prescribing seen 
in many SSA countries cannot be justified by the data on the aetiology of non-bloody diarrhoea 
and will only lead to antibiotic resistance and antibiotic-associated diarrhoea. Therefore, our 
findings underscore the need to educate both prescribers and parents in SSA on appropriate 
management of diarrhoea and the consequences of inappropriate use of antibiotics in children.  
This study, however, is not without limitations. Some countries in SSA were not included due 
to non-availability of DHS data for the study period considered. Also, the data used in this 
study was based on self-reported data and so liable to recall and social desirability biases 
which may result in under-estimation of the prevalence of antibiotics used in non-bloody 
diarrhoea. Despite these limitations, this study provides additional insight into the 
management of diarrhoea in SSA and could prompt appropriate health system response.  
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Table & Figure 
 
Figure 1: Meta-analysis for the prevalence of antibiotic use among cases of non-bloody 
diarrhoea 
Table 1: Prevalence of antibiotic use in non-bloody diarrhoea by demographic category 
Category Number of Children 
with non-bloody 
diarrhoea 
Prevalence estimate  
%  (95% CI) 
Test for association or 
trend  
Sex of child   X2 = 1.778, p = 0.182 
Male 18268 23.5 (19.9 – 27.1)  
Female 16809 22.9 (16.2 – 39.8)  
    
Age of child   X2 = 0.018, p = 0.893 
0 9307 21.1 (17.6 – 24.5)  
1 11395 25.0 (21.2 – 28.8)  
2 7040 22.9 (18.9 – 26.9)  
3 4413 22.1 (18.0 – 26.2)  
4 2922 22.0 (17.8 – 26.2)  
    
Currently breastfeeding   X2 = 13.485, p = 0.000 
No 13160 24.1 (20.0 – 28.2)  
Yes 21917 22.4 (18.9 – 26.0)  
    
Type of residence   X2 = 109.137, p = 0.000 
Urban 10771 26.7 (22.5 – 31.0)  
Rural 24306 21.6 (18.2 – 25.1)  
    
Wealth Index*   X2 = 176.047, p = 0.000 
Poor 16596 20.7 (16.9 – 24.5)  
Middle 6789 22.0 (18.6 – 25.5)  
Rich 11668 27.6 (23.6 – 31.6)  
    
Mother’s highest level of 
education* 
  X2 = 184.584, p = 0.000 
No education 14740 20.5 (17.2 – 23.8)  
Primary 12360 24.0 (20.4 – 27.7)  
Secondary  7352 27.9 (23.3 – 32.4)  
Higher 611 33.0 (26.1 – 39.8)  
    
Sources of care*   X2 = 3447.205, p = 
0.000 
Government hospitals 3131 38.5 (32.3 – 44.8)  
Government health centres 6184 35.2 (29.9 – 40.4)  
Government health 
posts/dispensaries 
2603 30.9 (24.4 – 37.5)  
Private hospitals/clinics 1347 41.1 (34.1 – 47.4)  
Community pharmacies 1391 41.8 (34.8 – 48.9)  
Shops 2321 33.6 (25.5 – 41.7)  
Market 1236 21.6 (6.9 – 36.3)  
Traditional practitioners 1011 5.0 (3.6  –  6.5)  
Others 1626 16.8 (11.8 – 21.9)  
Did not seek treatment from 
any provider 
14189 9.3 (7.3 - 11.2)  
N=35,077 *Category with some missing data 
 
 
